Navigation Links
Smokeless tobacco called 'moist snuff' is contaminated with harmful substances
Date:12/2/2009

A new study on the smokeless tobacco product called moist snuff placed between lip and gum has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens. Their study is published online in ACS' monthly journal Chemical Research in Toxicology. It reports that this category of tobacco products contains surprisingly high levels of certain toxic and cancer-causing substances. Called polycyclic aromatic hydrocarbons (PAHs), they may contribute to carcinogenic effects associated with smokeless tobacco use.

Irina Stepanov and colleagues note that use of moist snuff increased by almost 80 fold between 1986-2003, partially because of the notion that it is safer then cigarettes. While smokeless tobacco use is indeed associated with lower risk of cancer as compared to cigarette smoking, it can lead to precancerous oral lesions and oral, esophageal, and pancreatic cancer. Only trace amounts of one of the PAHs has been reported to be present in smokeless tobacco prior to the recent discovery by Stepanov and colleagues that at least eight PAHs are present in smokeless tobacco. This finding inspired the new research.

The scientists analyzed the PAHs in 23 moist snuff samples that included various flavors of the most popular brands sold in the U.S. They identified 23 different PAHs in the samples, of which 9 are classified as carcinogens. They conclude that PAHs are one of the most abundant groups of cancer-causing substances in moist snuff. "Urgent measures are required from the U.S. tobacco industry to modify manufacturing processes so that the levels of these toxicants and carcinogens in U.S. moist snuff are greatly reduced," the article notes.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert  

Page: 1

Related biology news :

1. Exposure to lead, tobacco smoke raises risk of ADHD
2. Novel mechanism revealed for increasing recombinant protein yield in tobacco
3. Women more vulnerable to tobacco carcinogens, new results show
4. Tobacco makes medicine
5. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
6. Infection blocks lungs protective response against tobacco smoke
7. UT researchers find link between advertising and increased tobacco use among Indias youth
8. Your babys brain on drugs (and alcohol and tobacco)
9. Scientists discover how cigarette smoke causes cancer: Study points to new treatments, safer tobacco
10. Does the desire to consume alcohol and tobacco come from our genetic makeup?
11. Scientific community called upon to resolve debate on net energy once and for all
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smokeless tobacco called 'moist snuff' is contaminated with harmful substances
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/23/2017)... , March 23, 2017 The report "Gesture Recognition ... Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the ... a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention to Biotechnology, ... research aimed at treating diseases and medical conditions. Under evaluation ... (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM Oncology ... complimentary research reports on these stocks now at: ... http://stock-callers.com/registration Biostage ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics ... Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial ... an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in ...
(Date:4/19/2017)... Calif. , April 19, 2017  As ... Drug Abuse and Heroin Summit ,  Proove® Biosciences, ... study analyzing genetics, environmental, and lifestyle factors to ... from the University of Southern California (USC), the ... , and Proove publish results showing that Proove ...
(Date:4/18/2017)... ... April 18, 2017 , ... ... Channel Partners 2017 Next-Gen Solution Provider. , Channel Partners program recognizes IT and ... their vision, innovation, and advocacy of the channel during transition and convergence. CallTower ...
Breaking Biology Technology: